Anthem (ANTM) Says Policy on Sarepta's (SRPT) DMD Drug Exondys 51 Unchanged - Bloomberg
- Wall Street dips as telecoms slump; AmEx surges
- Microsoft (MSFT) Tops Q1 EPS by 8c
- AMD (AMD) Posts Q3 Operating EPS of 3c; Sees Q4 Revenue Down Sequentially
- AT&T (T) Said to Discuss Idea of Takeover in Time Warner (TWX) Meetings
- Alkermes plc (ALKS) Announces Third ALKS 5461 Phase 3 Met Primary Endpoint in MDD
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MGT Capital (MGTI) Comments on Delisting; Knows No Facts, Circumstances Leading to Unilateral Decision
- NYSE to Suspend Trading in MGT Capital Investments (MGT); Will Move to Delist
- Sarepta Therapeutics (SRPT) Sees Intra-Day Selling Pressure
Create E-mail Alert Related CategoriesManagement Comments, Momentum Movers, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!